Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Procedure Code Q5135 Updated to Include Valid Diagnosis Code M0529

Last updated on

Effective May 14, 2026, for dates of service on or after October 1, 2024, the Texas Medicaid & Healthcare Partnership (TMHP) has deleted invalid diagnosis code M0259 and updated it to valid diagnosis code M0529 on injection tocilizumab-aazg (Tyenne) (procedure code Q5135).

The diagnosis code M0259 was incorrectly listed. The correct diagnosis code is M0529.

Claim Appeals and Processing

The Texas Health and Human Services Commission (HHSC) has waived the 120-day deadline for providers to file an appeal for denied Texas Medicaid claims.

TMHP will identify and reprocess any affected claims with dates of service on or after October 1, 2024. Providers do not need to appeal the claims unless the claims are denied for additional reasons after reprocessing is completed.

For more information, call the TMHP Contact Center at 800-925-9126 or the TMHP-CSHCN Services Program Contact Center at 800-568-2413.

Note: Texas Medicaid managed care organizations (MCOs) must provide all medically necessary, Medicaid-covered services to Medicaid members who are enrolled in their MCO. Administrative procedures, such as prior authorization, precertification, referrals, and claims and encounter data filing, may differ from traditional Medicaid (fee-for-service) and from MCO to MCO. Providers should contact the member’s specific MCO for details.